L-Norleucinamide-L-alpha-aspartyl-L-seryl-L-phenylalanyl-L-valylglycyl-L-leucyl-
-
L-Norleucinamide-L-alpha-aspartyl-L-seryl-L-phenylalanyl-L-valylglycyl-L-leucyl-
structure -
-
CAS No:
110863-33-7
-
Formula:
C35H56N8O10
-
Chemical Name:
L-Norleucinamide-L-alpha-aspartyl-L-seryl-L-phenylalanyl-L-valylglycyl-L-leucyl-
-
Synonyms:
10-Nle-neurokinin A (4-10);neurokinin A (4-10), Nle(10)-;neurokinin A (4-10), norleucine(10)-;Nle(10)-NKA(4-10);Neurokinin A (4-10), nle(10)-;110863-33-7;(Nle10)-Neurokinin A (4-10);CHEMBL2390989;(3S,6S,9S,12S,18S,21S)-3-amino-9-benzyl-21-carbamoyl-6-(hydroxymethyl)-18-isobutyl-12-isopropyl-4,7,10,13,16,19-hexaoxo-5,8,11,14,17,20-hexaazapentacosanoic acid;Nle(10)-nka(4-10);10-Nle-neurokinin A (4-10);Neurokinin A (4-10), norleucine(10)-;(Nle10)neurokinin A(4-10);DTXSID90911878;BDBM50435131;MFCD00076662;NCGC00167312-01;L-Norleucinamide-L-alpha-aspartyl-L-seryl-L-phenylalanyl-L-valylglycyl-L-leucyl-;(3S)-3-amino-4-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[2-[[(2S)-1-[[(2S)-1-amino-1-oxohexan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-2-oxoethyl]amino]-3-methyl-1-oxobutan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-4-oxobutanoic acid;3-Amino-9-benzyl-4,7,10,13,16,19-hexahydroxy-21-[hydroxy(imino)methyl]-6-(hydroxymethyl)-18-(2-methylpropyl)-12-(propan-2-yl)-5,8,11,14,17,20-hexaazapentacosa-4,7,10,13,16,19-hexaen-1-oic acid
-
CAS No:
L-Norleucinamide-L-alpha-aspartyl-L-seryl-L-phenylalanyl-L-valylglycyl-L-leucyl- Basic Attributes
748.9 g/mol
748.41194001 g/mol
Computed Properties
Molecular Weight:748.9
XLogP3:-2.2
Hydrogen Bond Donor Count:10
Hydrogen Bond Acceptor Count:11
Rotatable Bond Count:24
Exact Mass:748.41194001
Monoisotopic Mass:748.41194001
Topological Polar Surface Area:301
Heavy Atom Count:53
Complexity:1260
Defined Atom Stereocenter Count:6
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes
Request for Quotation